Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
4.850
+0.910 (23.10%)
At close: May 8, 2026, 4:00 PM EDT
4.720
-0.130 (-2.68%)
After-hours: May 8, 2026, 7:58 PM EDT
MRVI Market Cap
MRVI has a market cap or net worth of $1.25 billion as of May 8, 2026. Its market cap has increased by 320.22% in one year.
Market Cap
1.25B
Enterprise Value
1.40B
1-Year Change
320.22%
Ranking
Category
Stock Price
$4.85
Market Cap Chart
Since the IPO on November 20, 2020, MRVI's market cap has decreased from $2.43B to $1.25B, a decrease of -48.45%. That is a compound annual growth rate of -11.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 715.36M | 51.78% |
| Dec 31, 2025 | 471.32M | -39.03% |
| Dec 31, 2024 | 773.05M | -10.72% |
| Dec 29, 2023 | 865.84M | -54.00% |
| Dec 30, 2022 | 1.88B | -65.83% |
| Dec 31, 2021 | 5.51B | 100.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MapLight Therapeutics | 1.33B |
| Olema Pharmaceuticals | 1.32B |
| GH Research | 1.32B |
| Savara | 1.30B |
| Corvus Pharmaceuticals | 1.28B |
| Jade Biosciences | 1.27B |
| MoonLake Immunotherapeutics | 1.25B |
| DBV Technologies | 1.17B |